APO Research, Inc.

APO RESEARCH · REPORT

NC Immunoassay Membrane

Selected research

Market Outlook & Growth Opportunities

Global NC Immunoassay Membrane Market Outlook and Growth Opportunities 2026

Market perspective

The global NC Immunoassay Membrane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NC Immunoassay Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NC Immunoassay Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NC Immunoassay Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NC Immunoassay Membrane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NC Immunoassay Membrane market include Merck, Sartorius, Danaher (Cytiva), Advantec, Advanced Microdevices (MDI), Cobetter, Zhejiang Tailin Bioengineering, BSK Basic and Tianren, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NC Immunoassay Membrane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NC Immunoassay Membrane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NC Immunoassay Membrane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NC Immunoassay Membrane market size, projected growth trends, production technologies, key applications, and end-use industries.

NC Immunoassay Membrane Segment by Company

Merck

Sartorius

Danaher (Cytiva)

Advantec

Advanced Microdevices (MDI)

Cobetter

Zhejiang Tailin Bioengineering

BSK Basic

Tianren

Beijia New Material

Kingfa

Equinox Biotech

NC Immunoassay Membrane Segment by Type

Thickness max. 250 µm

Thickness above 250 µm

NC Immunoassay Membrane Segment by Application

Medical Diagnostics and Point-of-Care (POC)

Drug of Abuse Testing

Food Safety and Environmental

Other Applications

NC Immunoassay Membrane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NC Immunoassay Membrane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NC Immunoassay Membrane market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NC Immunoassay Membrane significant trends, drivers, influence factors in global and regions.

6. To analyze NC Immunoassay Membrane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NC Immunoassay Membrane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NC Immunoassay Membrane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NC Immunoassay Membrane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NC Immunoassay Membrane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NC Immunoassay Membrane industry.

Chapter 3: Detailed analysis of NC Immunoassay Membrane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NC Immunoassay Membrane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NC Immunoassay Membrane in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NC Immunoassay Membrane Industry Trends Table 2. NC Immunoassay Membrane Industry Drivers Table 3. NC Immunoassay Membrane Industry Opportunities and Challenges Table 4. NC Immunoassay Membrane Industry Restraints Table 5. Global NC Immunoassay Membrane Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NC Immunoassay Membrane Revenue Share by Company (2021-2026) Table 7. Global NC Immunoassay Membrane Sales Volume by Company (m²) & (2021-2026) Table 8. Global NC Immunoassay Membrane Sales Volume Share by Company (2021-2026) Table 9. Global NC Immunoassay Membrane Average Price (USD/m²) of Company (2021-2026) Table 10. Global NC Immunoassay Membrane Company Ranking, (2024-2026) & (USD Million) Table 11. Global NC Immunoassay Membrane Key Company Manufacturing Base & Headquarters Table 12. Global NC Immunoassay Membrane Company, Product Type & Application Table 13. Global NC Immunoassay Membrane Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NC Immunoassay Membrane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Thickness max. 250 µm Table 18. Significant Companies of Thickness above 250 µm Table 19. Global NC Immunoassay Membrane Sales Volume by Type 2021 VS 2025 VS 2032 (m²) Table 20. Global NC Immunoassay Membrane Sales Volume by Type (2021-2026) & (m²) Table 21. Global NC Immunoassay Membrane Sales Volume by Type (2027-2032) & (m²) Table 22. Global NC Immunoassay Membrane Sales Volume Share by Type (2021-2026) Table 23. Global NC Immunoassay Membrane Sales Volume Share by Type (2027-2032) Table 24. Global NC Immunoassay Membrane Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global NC Immunoassay Membrane Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global NC Immunoassay Membrane Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global NC Immunoassay Membrane Sales Value Share by Type (2021-2026) Table 28. Global NC Immunoassay Membrane Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Diagnostics and Point-of-Care (POC) Table 30. Significant Companies of Drug of Abuse Testing Table 31. Significant Companies of Food Safety and Environmental Table 32. Significant Companies of Other Applications Table 33. Global NC Immunoassay Membrane Sales Volume by Application 2021 VS 2025 VS 2032 (m²) Table 34. Global NC Immunoassay Membrane Sales Volume by Application (2021-2026) & (m²) Table 35. Global NC Immunoassay Membrane Sales Volume by Application (2027-2032) & (m²) Table 36. Global NC Immunoassay Membrane Sales Volume Share by Application (2021-2026) Table 37. Global NC Immunoassay Membrane Sales Volume Share by Application (2027-2032) Table 38. Global NC Immunoassay Membrane Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global NC Immunoassay Membrane Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global NC Immunoassay Membrane Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global NC Immunoassay Membrane Sales Value Share by Application (2021-2026) Table 42. Global NC Immunoassay Membrane Sales Value Share by Application (2027-2032) Table 43. Global NC Immunoassay Membrane Sales by Region: 2021 VS 2025 VS 2032 (m²) Table 44. Global NC Immunoassay Membrane Sales by Region (2021-2026) & (m²) Table 45. Global NC Immunoassay Membrane Sales Market Share by Region (2021-2026) Table 46. Global NC Immunoassay Membrane Sales by Region (2027-2032) & (m²) Table 47. Global NC Immunoassay Membrane Sales Market Share by Region (2027-2032) Table 48. Global NC Immunoassay Membrane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global NC Immunoassay Membrane Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global NC Immunoassay Membrane Sales Value Share by Region (2021-2026) Table 51. Global NC Immunoassay Membrane Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global NC Immunoassay Membrane Sales Value Share by Region (2027-2032) Table 53. Global NC Immunoassay Membrane Market Average Price (USD/m²) by Region (2021-2026) Table 54. Global NC Immunoassay Membrane Market Average Price (USD/m²) by Region (2027-2032) Table 55. Global NC Immunoassay Membrane Sales by Country: 2021 VS 2025 VS 2032 (m²) Table 56. Global NC Immunoassay Membrane Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global NC Immunoassay Membrane Sales by Country (2021-2026) & (m²) Table 58. Global NC Immunoassay Membrane Sales Market Share by Country (2021-2026) Table 59. Global NC Immunoassay Membrane Sales by Country (2027-2032) & (m²) Table 60. Global NC Immunoassay Membrane Sales Market Share by Country (2027-2032) Table 61. Global NC Immunoassay Membrane Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global NC Immunoassay Membrane Sales Value Market Share by Country (2021-2026) Table 63. Global NC Immunoassay Membrane Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global NC Immunoassay Membrane Sales Value Market Share by Country (2027-2032) Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 68. Merck NC Immunoassay Membrane Product Portfolio Table 69. Merck Recent Development Table 70. Sartorius Company Information Table 71. Sartorius Business Overview Table 72. Sartorius NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 73. Sartorius NC Immunoassay Membrane Product Portfolio Table 74. Sartorius Recent Development Table 75. Danaher (Cytiva) Company Information Table 76. Danaher (Cytiva) Business Overview Table 77. Danaher (Cytiva) NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 78. Danaher (Cytiva) NC Immunoassay Membrane Product Portfolio Table 79. Danaher (Cytiva) Recent Development Table 80. Advantec Company Information Table 81. Advantec Business Overview Table 82. Advantec NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 83. Advantec NC Immunoassay Membrane Product Portfolio Table 84. Advantec Recent Development Table 85. Advanced Microdevices (MDI) Company Information Table 86. Advanced Microdevices (MDI) Business Overview Table 87. Advanced Microdevices (MDI) NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 88. Advanced Microdevices (MDI) NC Immunoassay Membrane Product Portfolio Table 89. Advanced Microdevices (MDI) Recent Development Table 90. Cobetter Company Information Table 91. Cobetter Business Overview Table 92. Cobetter NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 93. Cobetter NC Immunoassay Membrane Product Portfolio Table 94. Cobetter Recent Development Table 95. Zhejiang Tailin Bioengineering Company Information Table 96. Zhejiang Tailin Bioengineering Business Overview Table 97. Zhejiang Tailin Bioengineering NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 98. Zhejiang Tailin Bioengineering NC Immunoassay Membrane Product Portfolio Table 99. Zhejiang Tailin Bioengineering Recent Development Table 100. BSK Basic Company Information Table 101. BSK Basic Business Overview Table 102. BSK Basic NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 103. BSK Basic NC Immunoassay Membrane Product Portfolio Table 104. BSK Basic Recent Development Table 105. Tianren Company Information Table 106. Tianren Business Overview Table 107. Tianren NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 108. Tianren NC Immunoassay Membrane Product Portfolio Table 109. Tianren Recent Development Table 110. Beijia New Material Company Information Table 111. Beijia New Material Business Overview Table 112. Beijia New Material NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 113. Beijia New Material NC Immunoassay Membrane Product Portfolio Table 114. Beijia New Material Recent Development Table 115. Kingfa Company Information Table 116. Kingfa Business Overview Table 117. Kingfa NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 118. Kingfa NC Immunoassay Membrane Product Portfolio Table 119. Kingfa Recent Development Table 120. Equinox Biotech Company Information Table 121. Equinox Biotech Business Overview Table 122. Equinox Biotech NC Immunoassay Membrane Sales (m²), Value (US$ Million), Price (USD/m²) and Gross Margin (2021-2026) Table 123. Equinox Biotech NC Immunoassay Membrane Product Portfolio Table 124. Equinox Biotech Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. NC Immunoassay Membrane Distributors List Table 128. NC Immunoassay Membrane Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. NC Immunoassay Membrane Product Image Figure 2. Global NC Immunoassay Membrane Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NC Immunoassay Membrane Sales Value (2021-2032) & (US$ Million) Figure 4. Global NC Immunoassay Membrane Sales (2021-2032) & (m²) Figure 5. Global NC Immunoassay Membrane Sales Average Price (USD/m²) & (2021-2032) Figure 6. Global NC Immunoassay Membrane Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Thickness max. 250 µm Image Figure 10. Thickness above 250 µm Image Figure 11. Global NC Immunoassay Membrane Sales Volume by Type (2021 VS 2025 VS 2032) & (m²) Figure 12. Global NC Immunoassay Membrane Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global NC Immunoassay Membrane Sales Volume Share by Type (2021-2032) Figure 14. Global NC Immunoassay Membrane Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global NC Immunoassay Membrane Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global NC Immunoassay Membrane Sales Value Share by Type (2021-2032) Figure 17. Medical Diagnostics and Point-of-Care (POC) Image Figure 18. Drug of Abuse Testing Image Figure 19. Food Safety and Environmental Image Figure 20. Other Applications Image Figure 21. Global NC Immunoassay Membrane Sales Volume by Application (2021 VS 2025 VS 2032) & (m²) Figure 22. Global NC Immunoassay Membrane Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global NC Immunoassay Membrane Sales Volume Share by Application (2021-2032) Figure 24. Global NC Immunoassay Membrane Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global NC Immunoassay Membrane Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global NC Immunoassay Membrane Sales Value Share by Application (2021-2032) Figure 27. Global NC Immunoassay Membrane Sales by Region: 2021 VS 2025 VS 2032 (m²) Figure 28. Global NC Immunoassay Membrane Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global NC Immunoassay Membrane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global NC Immunoassay Membrane Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America NC Immunoassay Membrane Sales Value (2021-2032) & (US$ Million) Figure 32. North America NC Immunoassay Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe NC Immunoassay Membrane Sales Value (2021-2032) & (US$ Million) Figure 34. Europe NC Immunoassay Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific NC Immunoassay Membrane Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific NC Immunoassay Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America NC Immunoassay Membrane Sales Value (2021-2032) & (US$ Million) Figure 38. South America NC Immunoassay Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa NC Immunoassay Membrane Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa NC Immunoassay Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt NC Immunoassay Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. NC Immunoassay Membrane Value Chain Figure 126. Manufacturing Cost Structure Figure 127. NC Immunoassay Membrane Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Thickness max. 250 µm
  • Thickness above 250 µm
Applications
  • Medical Diagnostics and Point-of-Care (POC)
  • Drug of Abuse Testing
  • Food Safety and Environmental
  • Other Applications
Companies covered
  • Merck
  • Sartorius
  • Danaher (Cytiva)
  • Advantec
  • Advanced Microdevices (MDI)
  • Cobetter
  • Zhejiang Tailin Bioengineering
  • BSK Basic
  • Tianren
  • Beijia New Material
  • Kingfa
  • Equinox Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NC Immunoassay Membrane Sales Value (2021-2032)
  4. 1.2.2 Global NC Immunoassay Membrane Sales Volume (2021-2032)
  5. 1.2.3 Global NC Immunoassay Membrane Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NC Immunoassay Membrane Market Dynamics
  1. 2.1 NC Immunoassay Membrane Industry Trends
  2. 2.2 NC Immunoassay Membrane Industry Drivers
  3. 2.3 NC Immunoassay Membrane Industry Opportunities and Challenges
  4. 2.4 NC Immunoassay Membrane Industry Restraints
3 NC Immunoassay Membrane Market by Company
  1. 3.1 Global NC Immunoassay Membrane Company Revenue Ranking in 2025
  2. 3.2 Global NC Immunoassay Membrane Revenue by Company (2021-2026)
  3. 3.3 Global NC Immunoassay Membrane Sales Volume by Company (2021-2026)
  4. 3.4 Global NC Immunoassay Membrane Average Price by Company (2021-2026)
  5. 3.5 Global NC Immunoassay Membrane Company Ranking (2024-2026)
  6. 3.6 Global NC Immunoassay Membrane Company Manufacturing Base and Headquarters
  7. 3.7 Global NC Immunoassay Membrane Company Product Type and Application
  8. 3.8 Global NC Immunoassay Membrane Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NC Immunoassay Membrane Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NC Immunoassay Membrane Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NC Immunoassay Membrane Market by Type
  1. 4.1 NC Immunoassay Membrane Type Introduction
  2. 4.1.1 Thickness max. 250 µm
  3. 4.1.2 Thickness above 250 µm
  4. 4.2 Global NC Immunoassay Membrane Sales Volume by Type
  5. 4.2.1 Global NC Immunoassay Membrane Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global NC Immunoassay Membrane Sales Volume by Type (2021-2032)
  7. 4.2.3 Global NC Immunoassay Membrane Sales Volume Share by Type (2021-2032)
  8. 4.3 Global NC Immunoassay Membrane Sales Value by Type
  9. 4.3.1 Global NC Immunoassay Membrane Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global NC Immunoassay Membrane Sales Value by Type (2021-2032)
  11. 4.3.3 Global NC Immunoassay Membrane Sales Value Share by Type (2021-2032)
5 NC Immunoassay Membrane Market by Application
  1. 5.1 NC Immunoassay Membrane Application Introduction
  2. 5.1.1 Medical Diagnostics and Point-of-Care (POC)
  3. 5.1.2 Drug of Abuse Testing
  4. 5.1.3 Food Safety and Environmental
  5. 5.1.4 Other Applications
  6. 5.2 Global NC Immunoassay Membrane Sales Volume by Application
  7. 5.2.1 Global NC Immunoassay Membrane Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global NC Immunoassay Membrane Sales Volume by Application (2021-2032)
  9. 5.2.3 Global NC Immunoassay Membrane Sales Volume Share by Application (2021-2032)
  10. 5.3 Global NC Immunoassay Membrane Sales Value by Application
  11. 5.3.1 Global NC Immunoassay Membrane Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global NC Immunoassay Membrane Sales Value by Application (2021-2032)
  13. 5.3.3 Global NC Immunoassay Membrane Sales Value Share by Application (2021-2032)
6 NC Immunoassay Membrane Regional Sales and Value Analysis
  1. 6.1 Global NC Immunoassay Membrane Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NC Immunoassay Membrane Sales by Region (2021-2032)
  3. 6.2.1 Global NC Immunoassay Membrane Sales by Region: 2021-2026
  4. 6.2.2 Global NC Immunoassay Membrane Sales by Region (2027-2032)
  5. 6.3 Global NC Immunoassay Membrane Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NC Immunoassay Membrane Sales Value by Region (2021-2032)
  7. 6.4.1 Global NC Immunoassay Membrane Sales Value by Region: 2021-2026
  8. 6.4.2 Global NC Immunoassay Membrane Sales Value by Region (2027-2032)
  9. 6.5 Global NC Immunoassay Membrane Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NC Immunoassay Membrane Sales Value (2021-2032)
  12. 6.6.2 North America NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NC Immunoassay Membrane Sales Value (2021-2032)
  15. 6.7.2 Europe NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NC Immunoassay Membrane Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NC Immunoassay Membrane Sales Value (2021-2032)
  21. 6.9.2 South America NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NC Immunoassay Membrane Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NC Immunoassay Membrane Sales Value Share by Country, 2025 VS 2032
7 NC Immunoassay Membrane Country-level Sales and Value Analysis
  1. 7.1 Global NC Immunoassay Membrane Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NC Immunoassay Membrane Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NC Immunoassay Membrane Sales by Country (2021-2032)
  4. 7.3.1 Global NC Immunoassay Membrane Sales by Country (2021-2026)
  5. 7.3.2 Global NC Immunoassay Membrane Sales by Country (2027-2032)
  6. 7.4 Global NC Immunoassay Membrane Sales Value by Country (2021-2032)
  7. 7.4.1 Global NC Immunoassay Membrane Sales Value by Country (2021-2026)
  8. 7.4.2 Global NC Immunoassay Membrane Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NC Immunoassay Membrane Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NC Immunoassay Membrane Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NC Immunoassay Membrane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck NC Immunoassay Membrane Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Sartorius
  8. 8.2.1 Sartorius Company Information
  9. 8.2.2 Sartorius Business Overview
  10. 8.2.3 Sartorius NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sartorius NC Immunoassay Membrane Product Portfolio
  12. 8.2.5 Sartorius Recent Developments
  13. 8.3 Danaher (Cytiva)
  14. 8.3.1 Danaher (Cytiva) Company Information
  15. 8.3.2 Danaher (Cytiva) Business Overview
  16. 8.3.3 Danaher (Cytiva) NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Danaher (Cytiva) NC Immunoassay Membrane Product Portfolio
  18. 8.3.5 Danaher (Cytiva) Recent Developments
  19. 8.4 Advantec
  20. 8.4.1 Advantec Company Information
  21. 8.4.2 Advantec Business Overview
  22. 8.4.3 Advantec NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Advantec NC Immunoassay Membrane Product Portfolio
  24. 8.4.5 Advantec Recent Developments
  25. 8.5 Advanced Microdevices (MDI)
  26. 8.5.1 Advanced Microdevices (MDI) Company Information
  27. 8.5.2 Advanced Microdevices (MDI) Business Overview
  28. 8.5.3 Advanced Microdevices (MDI) NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Advanced Microdevices (MDI) NC Immunoassay Membrane Product Portfolio
  30. 8.5.5 Advanced Microdevices (MDI) Recent Developments
  31. 8.6 Cobetter
  32. 8.6.1 Cobetter Company Information
  33. 8.6.2 Cobetter Business Overview
  34. 8.6.3 Cobetter NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cobetter NC Immunoassay Membrane Product Portfolio
  36. 8.6.5 Cobetter Recent Developments
  37. 8.7 Zhejiang Tailin Bioengineering
  38. 8.7.1 Zhejiang Tailin Bioengineering Company Information
  39. 8.7.2 Zhejiang Tailin Bioengineering Business Overview
  40. 8.7.3 Zhejiang Tailin Bioengineering NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zhejiang Tailin Bioengineering NC Immunoassay Membrane Product Portfolio
  42. 8.7.5 Zhejiang Tailin Bioengineering Recent Developments
  43. 8.8 BSK Basic
  44. 8.8.1 BSK Basic Company Information
  45. 8.8.2 BSK Basic Business Overview
  46. 8.8.3 BSK Basic NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BSK Basic NC Immunoassay Membrane Product Portfolio
  48. 8.8.5 BSK Basic Recent Developments
  49. 8.9 Tianren
  50. 8.9.1 Tianren Company Information
  51. 8.9.2 Tianren Business Overview
  52. 8.9.3 Tianren NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Tianren NC Immunoassay Membrane Product Portfolio
  54. 8.9.5 Tianren Recent Developments
  55. 8.10 Beijia New Material
  56. 8.10.1 Beijia New Material Company Information
  57. 8.10.2 Beijia New Material Business Overview
  58. 8.10.3 Beijia New Material NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Beijia New Material NC Immunoassay Membrane Product Portfolio
  60. 8.10.5 Beijia New Material Recent Developments
  61. 8.11 Kingfa
  62. 8.11.1 Kingfa Company Information
  63. 8.11.2 Kingfa Business Overview
  64. 8.11.3 Kingfa NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kingfa NC Immunoassay Membrane Product Portfolio
  66. 8.11.5 Kingfa Recent Developments
  67. 8.12 Equinox Biotech
  68. 8.12.1 Equinox Biotech Company Information
  69. 8.12.2 Equinox Biotech Business Overview
  70. 8.12.3 Equinox Biotech NC Immunoassay Membrane Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Equinox Biotech NC Immunoassay Membrane Product Portfolio
  72. 8.12.5 Equinox Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NC Immunoassay Membrane Value Chain Analysis
  2. 9.1.1 NC Immunoassay Membrane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NC Immunoassay Membrane Sales Mode & Process
  6. 9.2 NC Immunoassay Membrane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NC Immunoassay Membrane Distributors
  9. 9.2.3 NC Immunoassay Membrane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.